BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22568914)

  • 1. Interfering nanoparticles for silencing microRNAs.
    Baigude H; Rana TM
    Methods Enzymol; 2012; 509():339-53. PubMed ID: 22568914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing microRNA by interfering nanoparticles in mice.
    Su J; Baigude H; McCarroll J; Rana TM
    Nucleic Acids Res; 2011 Mar; 39(6):e38. PubMed ID: 21212128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
    Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.
    Zeng Y; Yi R; Cullen BR
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9779-84. PubMed ID: 12902540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of miRNA targets in skeletal muscle cells.
    Huang ZP; Espinoza-Lewis R; Wang DZ
    Methods Mol Biol; 2012; 798():475-90. PubMed ID: 22130855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene silencing in vitro and in vivo using intronic microRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2013; 936():209-29. PubMed ID: 23007511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled expression of functional miR-122 with a ligand inducible expression system.
    Shea CM; Tzertzinis G
    BMC Biotechnol; 2010 Oct; 10():76. PubMed ID: 20961424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and creation of new nanomaterials for therapeutic RNAi.
    Baigude H; McCarroll J; Yang CS; Swain PM; Rana TM
    ACS Chem Biol; 2007 Apr; 2(4):237-41. PubMed ID: 17432823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function.
    Connelly CM; Thomas M; Deiters A
    J Biomol Screen; 2012 Jul; 17(6):822-8. PubMed ID: 22412086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Delivery of RNAi by Reducible Interfering Nanoparticles (iNOPs).
    Baigude H; Su J; McCarroll J; Rana TM
    ACS Med Chem Lett; 2013 Aug; 4(8):720-723. PubMed ID: 24319542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2018; 1733():107-126. PubMed ID: 29435927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
    Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing in vitro and in vivo using intronic microRNAs.
    Deng JH; Deng P; Lin SL; Ying SY
    Methods Mol Biol; 2015; 1218():321-40. PubMed ID: 25319661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-27 Inhibits Adenovirus Infection by Suppressing the Expression of SNAP25 and TXN2.
    Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Tachibana M; Mizuguchi H
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a microRNA expression vector for function analysis of microRNA.
    Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
    J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
    Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.